SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-19-099432
Filing Date
2019-04-05
Accepted
2019-04-05 17:26:32
Documents
1
Period of Report
2019-04-05
Items
Item 1.01: Entry into a Material Definitive Agreement

Document Format Files

Seq Description Document Type Size
1 8-K d703502d8k.htm 8-K 16206
  Complete submission text file 0001193125-19-099432.txt   17293
Mailing Address 40 ERIE STREET SUITE 130 CAMBRIDGE MA 02139
Business Address 40 ERIE STREET SUITE 130 CAMBRIDGE MA 02139 857-285-6200
Intellia Therapeutics, Inc. (Filer) CIK: 0001652130 (see all company filings)

IRS No.: 364785571 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37766 | Film No.: 19735988
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
Office of Life Sciences